206. 脆弱X症候群 Fragile X syndrome Clinical trials / Disease details


臨床試験数 : 104 薬物数 : 87 - (DrugBank : 32) / 標的遺伝子数 : 54 - 標的パスウェイ数 : 79

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04823052
(ClinicalTrials.gov)
January 202224/3/2021Investigation of Sulindac in Male Fragile X Syndrome Patients Aged 13-40A Phase IIa, Double-blind, Placebo-controlled Adaptive Design Study to Explore the Safety and Efficacy of Sulindac (HX02_01) Alone and Subsequently in Combination With Other Drugs in Adolescent and Adult Males With Fragile X Syndrome (FXS)Fragile X SyndromeDrug: Sulindac, dose strength 1;Drug: Sulindac, dose strength 2;Drug: PlaceboHealx LimitedNULLNot yet recruiting13 Years40 YearsMale36Phase 2United States